Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single Dose Clinical Trial to Study the Safety of ART-I02 in Patients With Arthritis

NCT02727764 is registered in ClinicalTrials.gov with Arthrogen as lead sponsor.

NCT NCT02727764
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02727764 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single Dose Clinical Trial to Study the Safety of ART-I02 in Patients With Arthritis
Lead sponsor
Arthrogen
Phase
Phase 1
Overall status
Unknown status
Start date
April 20, 2017
Completion date
September 30, 2022
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arthritis, rheumatoid, osteo arthritis